Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
08/1999
08/12/1999WO1999040115A2 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT
08/12/1999WO1999040104A1 Neokine protein and nucleic acid molecules and uses therefor
08/12/1999WO1999039741A2 Systemic delivery of serum stable plasmid lipid particles for cancer therapy
08/12/1999WO1999039740A2 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
08/12/1999WO1999039738A1 Targeted delivery of biologically active media
08/12/1999WO1999039732A1 Pharmaceutical compositions comprising peg-asparaginase for the treatment of hiv infections
08/12/1999WO1999039727A1 Costimulatory blockade and mixed chimerism in allotransplantation
08/12/1999WO1999039726A1 Costimulatory blockade and mixed chimerism in transplantation
08/12/1999WO1999039722A2 Compositions and methods for separating lens epithelial cells and preventing posterior capsular opacification
08/12/1999WO1999039721A1 Chelated 8-hydroxyquinoline for the treatment of epithelial lesions
08/12/1999WO1999039720A1 Compositions and methods for modulating cytokine release in response to genotoxic agents
08/12/1999WO1999039702A2 Method for regulating size and growth of vascularized normal tissue
08/12/1999WO1999039647A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
08/12/1999WO1999031230A3 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof
08/12/1999WO1999029339A3 Prevention and/or treatment of allergic conditions
08/12/1999WO1999027919A3 Cyp2a enzymes and their use in therapeutic and diagnostic methods
08/12/1999WO1999026606A3 SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS
08/12/1999WO1999024471A9 Opiate, cannabinoid, and estrogen receptors
08/12/1999WO1999021574A9 Enhancement of morphogen activity
08/12/1999WO1999004820A3 Cytolysis of target cells by superantigen conjugates inducing t-cell activation
08/12/1999WO1999002143A3 Medicament comprising adenosine
08/12/1999WO1998058633A3 Microdose therapy of vascular conditions by no donors
08/12/1999WO1998057662A3 Therapeutic systems
08/12/1999WO1998053850A3 Compositions and means for the treatment of burns and other cutaneous traumas
08/12/1999WO1998048784A3 Method and composition for modulating amyloidosis
08/12/1999WO1996037199A8 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
08/12/1999DE19801265C1 Inhibierung von CD95-unabhängiger Apoptose bei AIDS Inhibiting CD95-independent apoptosis in AIDS
08/12/1999CA2321175A1 Method of screening therapeutic agents
08/12/1999CA2320300A1 Apparatus and method for inhibiting restenosis by applying ultrasound energy together with drugs
08/12/1999CA2320144A1 Neokine protein and nucleic acid molecules and uses therefor
08/12/1999CA2320098A1 Compositions and methods to inhibit formation of the c5b-9 complex of complement
08/12/1999CA2319764A1 Costimulatory blockade and mixed chimerism in transplantation
08/12/1999CA2319567A1 Compositions and methods for modulating cytokine release in response to genotoxic agents
08/12/1999CA2319468A1 Sensitizing cells to compounds using lipid-mediated gene and compound delivery
08/12/1999CA2319448A1 Costimulatory blockade and mixed chimerism in allotransplantation
08/12/1999CA2319356A1 Composition and methods for treatment of hiv infection
08/12/1999CA2316860A1 Three-dimensional structures and models of fc receptors and uses thereof
08/11/1999EP0935000A2 Orphan receptor
08/11/1999EP0934742A2 High glycerin containing anti-microbial cleansers
08/11/1999EP0934531A1 Diagnosis of spongiform encephalopathy
08/11/1999EP0934528A1 A method for the identification of compounds with anxiolytic potential
08/11/1999EP0934413A1 Placental-derived prostate growth factors
08/11/1999EP0934411A1 Compositions for treating anemia
08/11/1999EP0934409A2 Diabetes-mediating proteins and therapeutic uses thereof
08/11/1999EP0934341A1 Inclusion complexes of beta-2-andrenergics for oral mucosal delivery
08/11/1999EP0934340A1 Novel compounds
08/11/1999EP0934336A1 Novel compounds
08/11/1999EP0934335A1 Novel compounds
08/11/1999EP0934290A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same
08/11/1999EP0934270A1 A method of treating cancer
08/11/1999EP0934081A2 Antineoplastic conjugates of transferrin, albumin and polyethylene glycol
08/11/1999EP0933995A1 Method of treating endothelial injury
08/11/1999EP0666741B1 Dithiocarbamates for the treatment of atherosclerosis and other cardiovascular and inflammatory diseases
08/11/1999EP0584185B1 Treatment of fatigue syndrome with cholinesterase inhibitors
08/11/1999CN1225682A Method and compositions for regulating T cell subsets by modulating transcription facter activity
08/11/1999CN1225653A Antiviral linear polymer
08/11/1999CN1225587A Compositions comprising an HIV protease inhibitor such as VX 478 and a water soluble vitamin E compound such as vitamin E-TPGS
08/11/1999CN1225582A Use of carbonic anhydrase inhibitors for treating macular edema
08/11/1999CN1225579A Granulates of hexalhydropyrazine derivatives which can be administered orally
08/11/1999CN1225555A Teat dipping agent
08/10/1999US5935962 Administering doxazosin, a metabolite or a salt
08/10/1999US5935954 Compounds with improved multi-drug resistance activity
08/10/1999US5935945 Methods of treating or preventing cardiac arrhythmia
08/10/1999US5935942 Co-administering a fluorescent dye encapsulated within a heat-sensitive liposome and tissue reactive agent activated by irradiation, selectively heating, monitoring, activating by irradiating
08/10/1999US5935931 Human apoptosis-related calcium-binding protein
08/10/1999US5935929 Methods for treating interstitial lung disease by using interleukin-9 and its antagonists
08/10/1999US5935927 Alzheimer*s disease, diabetes; removal amyloid from brain, pancreas
08/10/1999US5935860 Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia
08/10/1999US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase.
08/10/1999US5935817 Genetic engineering
08/10/1999US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds
08/10/1999US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections
08/10/1999US5935813 Human pancreatitis-associated protein
08/10/1999US5935812 Polynucleotide
08/10/1999US5935781 Apolipoprotein E polymorphism and treatment of Alzheimer's disease
08/10/1999US5935610 Antacid comprising magnesium oxide, calcium carbonate and avitamine, mineral supplement for reducing stomach acidity while at the same time providing a nutritional supplement
08/10/1999US5935586 Therapeutic/cosmetic compositions comprising CGRP antagonists for treating disease states of the skin
08/10/1999US5935575 Interleukin-4 stimulated T lymphocyte cell death for the treatment of allergic disorders
08/10/1999US5935564 Use of hydrophobic interaction chromatography to purify polyethylene glycols
08/10/1999CA2143418C Medical foods for the nutritional support of child/adult metabolic diseases
08/10/1999CA2098593C Treatment method for cancer
08/10/1999CA2093434C Regulation of immunoglobulin production by interleukin-9
08/09/1999WO1999039680A1 Antifungal nail lacquer and method using same
08/05/1999WO1999039238A1 Methods and apparatus for accelerated orthokeratology
08/05/1999WO1999038998A1 Methods of identifying modulators of kinases responsive to stress
08/05/1999WO1999038983A1 Novel sphingosine-1 phosphate lyase
08/05/1999WO1999038981A2 Human protein kinase molecules
08/05/1999WO1999038969A1 PROTEIN HUMAINE β-TrCP
08/05/1999WO1999038964A2 Promoter regions of the mouse and human telomerase rna component genes
08/05/1999WO1999038889A2 Modulation of sodium channels in dorsal root ganglia
08/05/1999WO1999038881A1 67 human secreted proteins
08/05/1999WO1999038827A1 PLATELET AGGREGATION INHIBITION USING LOW MOLECULAR WEIGHT HEPARIN IN COMBINATION WITH A GP IIb/IIIa ANTAGONIST
08/05/1999WO1999038532A2 Methods for the prevention and treatment of fibrosis and sclerosis
08/05/1999WO1999038531A1 TREATING ATOPIC DERMATITIS WITH IgE ANTAGONISTS
08/05/1999WO1999038525A1 Treatment of follicular lymphomas using inhibitors of the lymphotoxin (lt) pathway
08/05/1999WO1999038521A1 The use of combinations of active agents consisting of antimicrobially active substances and plant extracts containing terpene in veterinary medicine
08/05/1999WO1999038501A2 Method of regulating glucose metabolism, and reagents related thereto
08/05/1999WO1999038498A1 Method for treating alzheimer's disease
08/05/1999WO1999038492A1 Nasal solutions
08/05/1999WO1999038472A2 Topical vasodilatory gel composition and methods of use and production
1 ... 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 1032 ... 1151